Evers LM - Search Results

1

Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.

Kersten MJ, Evers LM, Dellemijn PL, van den Berg H, Portegies P, Hintzen RQ, van Lier RA, von dem Borne AE, van Oers RH. Kersten MJ, et al. Among authors: evers lm. Blood. 1996 Mar 1;87(5):1985-9. Blood. 1996. PMID: 8634448 Free article.

2

Expression and release of CD27 in human B-cell malignancies.

van Oers MH, Pals ST, Evers LM, van der Schoot CE, Koopman G, Bonfrer JM, Hintzen RQ, von dem Borne AE, van Lier RA. van Oers MH, et al. Among authors: evers lm. Blood. 1993 Dec 1;82(11):3430-6. Blood. 1993. PMID: 8241510 Free article.

3

Addition of granulocyte colony-stimulating factor to chemotherapy in patients with AIDS-related lymphoma: effects on neutrophil Fc gamma receptor expression and soluble Fc gammaRIII plasma levels.

Kersten MJ, de Jong S, Evers LM, Koene HR, van Oers MH. Kersten MJ, et al. Among authors: evers lm. Br J Haematol. 1997 Dec;99(3):537-41. doi: 10.1046/j.1365-2141.1997.4293239.x. Br J Haematol. 1997. PMID: 9401062 Free article.

4

Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load.

Kersten MJ, Verduyn TJ, Reiss P, Evers LM, de Wolf F, van Oers MH. Kersten MJ, et al. Among authors: evers lm. Ann Oncol. 1998 Oct;9(10):1135-8. doi: 10.1023/a:1008484522952. Ann Oncol. 1998. PMID: 9834829 Free article. Clinical Trial.

5

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.

Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST. Derksen PW, et al. Among authors: evers lm. Blood. 2002 Feb 15;99(4):1405-10. doi: 10.1182/blood.v99.4.1405. Blood. 2002. PMID: 11830493 Free article.

6

CD20-induced B cell death can bypass mitochondria and caspase activation.

van der Kolk LE, Evers LM, Omene C, Lens SM, Lederman S, van Lier RA, van Oers MH, Eldering E. van der Kolk LE, et al. Among authors: evers lm. Leukemia. 2002 Sep;16(9):1735-44. doi: 10.1038/sj.leu.2402559. Leukemia. 2002. PMID: 12200688

7

Apoptosis via the B cell antigen receptor requires Bax translocation and involves mitochondrial depolarization, cytochrome C release, and caspase-9 activation.

Eldering E, Mackus WJ, Derks IA, Evers LM, Beuling E, Teeling P, Lens SM, van Oers MH, van Lier RA. Eldering E, et al. Among authors: evers lm. Eur J Immunol. 2004 Jul;34(7):1950-60. doi: 10.1002/eji.200324817. Eur J Immunol. 2004. PMID: 15214043 Free article.

8

CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.

Kater AP, Evers LM, Remmerswaal EB, Jaspers A, Oosterwijk MF, van Lier RA, van Oers MH, Eldering E. Kater AP, et al. Among authors: evers lm. Br J Haematol. 2004 Nov;127(4):404-15. doi: 10.1111/j.1365-2141.2004.05225.x. Br J Haematol. 2004. PMID: 15521917 Free article.

9

Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.

Mackus WJ, Kater AP, Grummels A, Evers LM, Hooijbrink B, Kramer MH, Castro JE, Kipps TJ, van Lier RA, van Oers MH, Eldering E. Mackus WJ, et al. Among authors: evers lm. Leukemia. 2005 Mar;19(3):427-34. doi: 10.1038/sj.leu.2403623. Leukemia. 2005. PMID: 15674362

10

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.

van der Straten L, Stege CAM, Kersting S, Nasserinejad K, Dubois J, Dobber JA, Mellink CHM, van der Kevie-Kersemaekers AF, Evers LM, de Boer F, Koene HR, Schreurs J, van der Klift M, Velders GA, van der Spek E, van der Straaten HM, Hoogendoorn M, van Gelder M, Posthuma EFM, Visser HPJ, Houtenbos I, Idink CAM, Issa DE, Dompeling EC, van Zaanen HCT, Veelken JH, Levenga H, Tick LW, Terpstra WE, Tonino SH, Westerweel PE, Langerak AW, Kater AP, Levin MD. van der Straten L, et al. Among authors: evers lm. Blood. 2023 Sep 28;142(13):1131-1142. doi: 10.1182/blood.2023020195. Blood. 2023. PMID: 37363833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page